Skip to main content

Anagrelide Hydrochloride Capsules Shortage

Last Updated: August 4, 2016
Status: Resolved

Reason for the Shortage
    • Mylan Pharmaceuticals discontinued anagrelide capsules in 2015.
    • Teva could not provide a reason for the shortage.
Available Products
    • Agrylin oral capsule, Shire, 0.5 mg, 100 count, NDC 54092-0063-01
    • Anagrelide Hydrochloride oral capsule, Teva, 0.5 mg, 100 count, NDC 00172-5241-60
    • Anagrelide Hydrochloride oral capsule, Teva, 1 mg, 100 count, NDC 00172-5240-60

Estimated Resupply Dates

    • All marketed presentations are available.


Updated August 4, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 6, 2016 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.